Pocket Crafter: A 3D Generative Modeling Based Workflow for the Rapid Generation of Hit Molecules in Drug Discovery

09 October 2023, Version 1
This content is a preprint and has not undergone peer review at the time of posting.

Abstract

We present a user-friendly molecular generative pipeline called Pocket Crafter, specifically designed to facilitate hit finding activity in the drug discovery process. This workflow utilized a 3D (three-dimensional) generative modeling method, e.g. Pocket2Mol, for the de novo design of molecules in spatial perspective for the targeted protein structures, followed by filters for chemical-physical properties and drug-likeness, SAR (structure-activity relationship) analysis, and clustering to generate top virtual hit scaffolds. In our WDR5 case study, we acquired a focused set of 2029 compounds after a targeted searching within Novartis archived library based on the virtual scaffolds. Subsequently, we experimentally profiled these compounds, resulting in a novel chemical scaffold series that demonstrated activity in biochemical and biophysical assays. Pocket Crafter successfully prototyped an effective end-to-end 3D generative chemistry-based workflow for the exploration of new chemical scaffolds, which represents a promising approach in early drug discovery for the identification of novel active compounds.

Keywords

Pocket Crafter
Hit Finding
Virtual Screening
3D Generative Chemistry
Generative Chemistry
Library Design

Supplementary materials

Title
Description
Actions
Title
Material 1: PC compound structures
Description
PC compound structures
Actions
Title
Material 2: Protein Ligand Interaction Fingerprints (PLIF) summary
Description
Protein Ligand Interaction Fingerprints (PLIF) summary
Actions

Comments

Comments are not moderated before they are posted, but they can be removed by the site moderators if they are found to be in contravention of our Commenting Policy [opens in a new tab] - please read this policy before you post. Comments should be used for scholarly discussion of the content in question. You can find more information about how to use the commenting feature here [opens in a new tab] .
This site is protected by reCAPTCHA and the Google Privacy Policy [opens in a new tab] and Terms of Service [opens in a new tab] apply.